June 17, 2019 / 10:54 AM / 3 months ago

Pfizer to buy Array for $10.64 bln

June 17 (Reuters) - Pfizer Inc said on Monday it had agreed to acquire Array Biopharma Inc for $10.64 billion, which will grant it access to its cancer drugs.

The cash deal for $48 per share of Array represents a premium of about 62% to the stock's closing price on Friday. (Reporting by Tamara Mathias in Bengaluru; Editing by James Emmanuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below